Zenivex^® E20 Mosquito Adulticide
A new alternative in adult mosquito control

Zenivex^® E20 from Central Life Sciences is a new adulticide for mosquito abatement professionals who want to provide reliable control of adult mosquito populations. Zenivex^® E20 is a low odor formulation that works on contact and has these advantages:

• No Piperonyl Butoxide (PBO), no synergist
• Ability to use diluted or undiluted
• Quick, permanent knockdown
• Low use rates
• Environmental Protection Agency (EPA) reduced risk classification

The active advantage — Etofenprox

The active ingredient in Zenivex^® E20 is Etofenprox (20% by weight), a unique molecule that is new in the control of adult mosquitoes. The EPA has classified Etofenprox as reduced risk, making Zenivex^® E20 the ideal choice in mosquito adulticides. Etofenprox also has the following advantages:

• Low odor
• Non–ester pyrethroid
• Unique molecule
• Effective on organophosphate resistant mosquitoes
• Sodium channel blocker
• Improved safety for operators and bystanders
• History of effectiveness

Etofenprox presents a low toxicity to birds and dried foliar residues are not harmful to honeybees. The following chart shows comparative acute toxicities through LD50 measurement.

*An LD50 is a measure of toxicity. The longer the LD50 bar, the lower the toxicity. Compared to the active ingredient in other leading mosquito control products, Etofenprox, the active ingredient in Zenivex^® E20, is the least toxic.

Made by professionals for professionals

Zenivex^® E20 offers a positive environmental profile. It is an oil-based formulation for use in Ultra Low Volume (ULV) and does not require dilution. It is ready-to-use for hand, ground or aerial application, and requires no aquatic setbacks.